• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE Back to Search Results
Model Number GF-UCT260
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Peritonitis (2252); Pseudoaneurysm (2605); Pancreatitis (4481); Unspecified Hepatic or Biliary Problem (4493)
Event Type  Injury  
Event Description
Olympus reviewed the following literature titled: endoscopic ultrasound-guided hepaticogastrostomy versus hepaticogastrostomy with antegrade stenting for malignant distal biliary obstruction.Literature summary.Recurrent biliary obstruction (rbo) is a possible complication of endoscopic ultrasound-guided hepaticogastrostomy (eus-hgs) in patients with malignant distal biliary obstruction (mdbo).Methods: we retrospectively evaluated consecutive patients who underwent eus-hgs or hgas.The trbo, overall survival (os), and adverse event (ae) rate were compared between the groups.Results: this study included 96 patients (eus-hgs, n = 58; hgas, n = 38).There was a significant difference in the cause of endoscopic retrograde cholangiopancreatography failure and the hgs stent type between the groups.Conclusions: endoscopic ultrasound-guided hepaticogastrostomy prolonged the trbo compared with eus-hgs for biliary drainage in patients with mdbo.Type of adverse events/number of patients.Recurrent biliary obstruction - 20 patients.Peritonitis - 5 patients.Cholangitis - 2 patients.Pancreatitis - 5 patients.Bleeding - 2 patients.Death 10 days after onset of septic shock - 1 patients.Pseudoaneurysm - 2 patients.Death in the follow up - 97 patients (not reportable).This article includes 6 complaints as follows: (b)(6) :na-u200h-8019s (septic shock/death).(b)(6) :na-u200h-8019s (for adverse events only).(b)(6) :gf-uct260 (septic shock/death).(b)(6) :gf-uct260 (for adverse events only).(b)(6) :jf-260v (septic shock/death).(b)(6) :jf-260v (for adverse events only).This report is 4 of 6 for (b)(6) :gf-uct260 (for adverse events only).
 
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Manufacturer Narrative
This supplemental report is being submitted to provide additional information from the author and the legal manufacturer's investigation.New information added to the following fields: h6, h10.The device history records (dhr) for this device could not be reviewed since the serial number was not provided.Olympus ships devices manufactured according to all applicable procedures and meet final product release criteria.A definitive root cause was not identified.Based on the available information, the legal manufacturer was unable to determine the probable cause of the adverse events since the device was not returned for evaluation.No malfunctions were reported.Olympus will continue to monitor field performance for this device.
 
Event Description
The author provided additional information: the olympus serial/lot numbers are unknown.The adverse events and deaths were not cause or contributed by an olympus device.The adverse events and deaths are attributed to an exacerbation of the disease.The device is not available for return.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE
Type of Device
ULTRASOUND GASTROVIDEOSCOPE
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer Contact
masaharu hirose
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8-061
JA   961-8061
426422891
MDR Report Key15294451
MDR Text Key298609881
Report Number3002808148-2022-01383
Device Sequence Number1
Product Code ODG
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGF-UCT260
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/27/2022
Initial Date FDA Received08/25/2022
Supplement Dates Manufacturer Received09/09/2022
Supplement Dates FDA Received10/06/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
UNK LOT/SERIAL: NA-U200H-8019S,JF-260V,TJF-260V
Patient Outcome(s) Other;
-
-